Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine - Concepedia

Concepedia

Publication | Open Access

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

DOI Full Paper Access

76

Citations

32

References

2020

Year

Marion Plaze, David Attali, Matthieu Prot, Anne‐Cécile Petit, Michael Blatzer, Fabien Vinckier, Laurine Levillayer, Jeanne Chiaravalli, Florent Perin-Dureau, Arnaud Cachia,

International Journal of Antimicrobial Agents

Human CellsMedicineImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral DrugFda-approved Drug ChlorpromazinePharmacologyDrug DiscoveryCovid-19

References

	Year	Citations

Page 1

Page 1